Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

interleukin-4 PE38KDEL immunotoxin

(in-ter-LOO-kin ... IH-myoo-noh-TOK-sin)

A substance being studied in the treatment of cancer. It is made by combining interleukin-4 with a bacterial toxin. Interleukin-4 PE38KDEL immunotoxin is a type of recombinant chimeric protein. Also called interleukin-4 PE38KDEL cytotoxin and NBI-3001.

interleukin-4 PE38KDEL immunotoxin

Search NCI's Dictionary of Cancer Terms